Great Point Partners as of June 30, 2020
Portfolio Holdings for Great Point Partners
Great Point Partners holds 36 positions in its portfolio as reported in the June 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Constellation Pharmceticls I | 8.4 | $105M | 3.5M | 30.05 | |
| Iovance Biotherapeutics (IOVA) | 8.2 | $102M | 3.7M | 27.45 | |
| Zymeworks | 7.4 | $93M | 2.6M | 36.07 | |
| ACADIA Pharmaceuticals (ACAD) | 7.0 | $88M | 1.8M | 48.47 | |
| Sage Therapeutics (SAGE) | 7.0 | $87M | 2.1M | 41.58 | |
| Arena Pharmaceuticals Com New | 6.6 | $82M | 1.3M | 62.95 | |
| United Therapeutics Corporation (UTHR) | 6.0 | $75M | 620k | 121.00 | |
| Tg Therapeutics (TGTX) | 5.2 | $65M | 3.3M | 19.48 | |
| Biohaven Pharmaceutical Holding | 4.9 | $62M | 841k | 73.11 | |
| Gw Pharmaceuticals Ads | 4.4 | $55M | 450k | 122.72 | |
| Akebia Therapeutics (AKBA) | 3.8 | $48M | 3.5M | 13.58 | |
| Macrogenics (MGNX) | 3.3 | $42M | 1.5M | 27.92 | |
| Cytokinetics Com New (CYTK) | 2.9 | $36M | 1.5M | 23.57 | |
| Global Blood Therapeutics In | 2.7 | $34M | 542k | 63.13 | |
| Geron Corporation (GERN) | 2.7 | $34M | 15M | 2.18 | |
| Vericel (VCEL) | 1.8 | $22M | 1.6M | 13.82 | |
| Prothena Corp SHS (PRTA) | 1.7 | $22M | 2.1M | 10.46 | |
| Nextcure (NXTC) | 1.7 | $21M | 1000k | 21.44 | |
| Abeona Therapeutics | 1.7 | $21M | 7.2M | 2.92 | |
| Glaukos (GKOS) | 1.5 | $19M | 500k | 38.42 | |
| Molecular Templates | 1.5 | $19M | 1.3M | 13.79 | |
| Ptc Therapeutics I (PTCT) | 1.3 | $17M | 330k | 50.74 | |
| Axonics Modulation Technolog (AXNX) | 1.3 | $16M | 460k | 35.11 | |
| Sangamo Biosciences (SGMO) | 1.1 | $14M | 1.6M | 8.96 | |
| Cytomx Therapeutics (CTMX) | 1.0 | $12M | 1.4M | 8.33 | |
| Calithera Biosciences | 1.0 | $12M | 2.3M | 5.28 | |
| Liquidia Technologies (LQDA) | 0.9 | $11M | 1.3M | 8.42 | |
| Arvinas Ord Call Option (ARVN) | 0.5 | $6.8M | 204k | 33.54 | |
| Denali Therapeutics (DNLI) | 0.5 | $6.8M | 280k | 24.18 | |
| Viewray (VRAYQ) | 0.5 | $6.2M | 2.8M | 2.24 | |
| Oyster Point Pharma | 0.5 | $6.2M | 215k | 28.88 | |
| Acceleron Pharma | 0.4 | $5.5M | 58k | 95.27 | |
| Kadmon Hldgs | 0.3 | $3.5M | 676k | 5.12 | |
| Millendo Therapeutics | 0.2 | $2.6M | 1.5M | 1.76 | |
| Puma Biotechnology (PBYI) | 0.1 | $965k | 93k | 10.43 | |
| Neoleukin Therapeutics | 0.0 | $233k | 14k | 16.57 |
